An economic study reveals wide-ranging costs in bringing new drugs to market, with pharmaceutical companies experiencing stable research and development (R&D) intensity, suggesting potential for reduced prices without compromising innovation.
The U.S. Food and Drug Administration issued draft guidance for drugmakers and medical device makers to improve diversity in clinical trials, emphasizing the importance of actions to support more equitable access to medical innovations.
Cyberattack on Ascension hospitals across the U.S. compromises patient care, leading to medication errors, delayed lab results, and patient safety risks, as health workers struggle without access to critical electronic systems.
A recent study analyzed melanoma trends in predominantly white populations across three regions, revealing significant increases in incidence rates and highlighting changing patterns of UV exposure. Source: The Journal of Investigative Dermatology
Conexiant
Daily News
Stay up to date with the latest clinical headlines.
The Congressional Budget Office projects a rise in the uninsured rate to 8.9% by 2034, driven by immigration and policy changes affecting young adults, despite a record low of 7.2% in 2023.
A study in JAMA Network Open shows a rise in influenza vaccination mandates for U.S. health care personnel, with VA hospitals increasing from 4% in 2017 to 96% in 2021.
Health care professionals welcome the FTC's new rule banning noncompete agreements but are concerned it may not protect those in nonprofit healthcare settings, potentially impacting most of the nation's medical professionals.
Researchers investigated the potential of a rare subset of T cells to predict which patients with advanced skin cancer may be responsive to immunotherapy.